Abstract
Histological assessment of nuclear morphology is a standard procedure in clinical practice. The implications of altered nuclear structure accompanying neoplastic disease are still not fully understood. Nuclear matrix proteins were considered as structural units defining the shape of nuclei. Consequently, it was assumed that nuclei displaying characteristics of cancer cells would exhibit specific nuclear matrix proteins. The nuclear proteome was investigated by various approaches, including analyses of preparations of whole nuclei, the nuclear matrix and of subnuclear compartments. Proteome alterations related to cancer were mainly investigated by comparative two dimensional polyacrylamide gel analyses. This review provides an overview of results achieved by this and other proteome analysis approaches, highlighting some implications of technical and analytical details. The contribution and future potential of proteomics to the further understanding of the chromatin regulation and mechanisms affecting nuclei during cell transformation will be discussed with regard to important advances accomplished by current techniques.
Keywords: nuclear matrix protein, cancer, proteomics, 2-d page, mass spectrometry
Current Proteomics
Title: Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Volume: 1 Issue: 2
Author(s): Christopher Gerner
Affiliation:
Keywords: nuclear matrix protein, cancer, proteomics, 2-d page, mass spectrometry
Abstract: Histological assessment of nuclear morphology is a standard procedure in clinical practice. The implications of altered nuclear structure accompanying neoplastic disease are still not fully understood. Nuclear matrix proteins were considered as structural units defining the shape of nuclei. Consequently, it was assumed that nuclei displaying characteristics of cancer cells would exhibit specific nuclear matrix proteins. The nuclear proteome was investigated by various approaches, including analyses of preparations of whole nuclei, the nuclear matrix and of subnuclear compartments. Proteome alterations related to cancer were mainly investigated by comparative two dimensional polyacrylamide gel analyses. This review provides an overview of results achieved by this and other proteome analysis approaches, highlighting some implications of technical and analytical details. The contribution and future potential of proteomics to the further understanding of the chromatin regulation and mechanisms affecting nuclei during cell transformation will be discussed with regard to important advances accomplished by current techniques.
Export Options
About this article
Cite this article as:
Gerner Christopher, Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**, Current Proteomics 2004; 1 (2) . https://dx.doi.org/10.2174/1570164043379406
DOI https://dx.doi.org/10.2174/1570164043379406 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index to Volume 3
Current Gene Therapy Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Recent Patents on Biotechnology Mitophagy in Carcinogenesis and Tumour Progression- A New Paradigm with Emerging Importance
Anti-Cancer Agents in Medicinal Chemistry Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Recent Progress in Discovery and Development of Antimitotic Agents
Anti-Cancer Agents in Medicinal Chemistry Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Recent Patents on Anti-Cancer Drug Discovery Targeting the Tumor Proteasome as a Mechanism to Control the Synthesis and Bioactivity of Matrix Macromolecules
Current Molecular Medicine P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Current Drug Metabolism Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery G and C Iterons and Strings in MicroRNAs Should be Important in Regulation of mRNAs<sup>†</sup>
MicroRNA A Survey on Machine Learning Based Medical Assistive Systems in Current Oncological Sciences
Current Medical Imaging Cyclooxygenases in Cancer: Chemoprevention and Sensitization to Conventional Therapies
Mini-Reviews in Medicinal Chemistry Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes
Current Radiopharmaceuticals Targeting Telomerase for Cancer Therapy
Current Cancer Therapy Reviews Imaging of Hypoxia Using PET and MRI
Current Pharmaceutical Biotechnology Chemoresistance in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy
Current Medicinal Chemistry Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
Anti-Cancer Agents in Medicinal Chemistry Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer
Current Cancer Drug Targets Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry